Predicting PARP inhibitor sensitivity and resistance

被引：4
|
作者：
Bebb, D. Gwyn [1 ,2 ]
Lees-Miller, Susan P. [2 ,3 ,4 ]
机构：
[1] Tom Baker Canc Clin, Div Med Oncol, Calgary, AB, Canada
[2] So Alberta Canc Res Inst, Calgary, AB, Canada
[3] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada
[4] Univ Calgary, Dept Oncol, Calgary, AB, Canada
来源：
CELL CYCLE | 2012年 / 11卷 / 22期
关键词：
HOMOLOGOUS RECOMBINATION; CELLS; ATM; DEFICIENCY;
D O I：
10.4161/cc.22604
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：4110 / 4110
页数：1
相关论文
共 50 条
  • [41] PARP inhibitor resistance: the underlying mechanisms and clinical implications
    Li, He
    Liu, Zhao-Yi
    Wu, Nayiyuan
    Chen, Yong-Chang
    Cheng, Quan
    Wang, Jing
    [J]. MOLECULAR CANCER, 2020, 19 (01)
  • [42] Sensitivity and resistance biomarkers to PARP inhibitors in Mcrpc.
    Mateo, Joaquin
    [J]. CANCER RESEARCH, 2018, 78 (16) : 21 - 22
  • [43] The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
    Luis Ordonez, Jose
    Teresa Amaral, Ana
    Carcaboso, Angel M.
    Herrero-Martin, David
    del Carmen Garcia-Macias, Maria
    Sevillano, Vicky
    Alonso, Diego
    Pascual-Pasto, Guillem
    San-Segundo, Laura
    Vila-Ubach, Monica
    Rodrigues, Telmo
    Fraile, Susana
    Teodosio, Cristina
    Mayo-Iscar, Agustin
    Aracil, Miguel
    Maria Galmarini, Carlos
    Tirado, Oscar M.
    Mora, Jaume
    de Alava, Enrique
    [J]. ONCOTARGET, 2015, 6 (22) : 18875 - 18890
  • [44] MET inhibitor sensitivity and resistance
    Krumbach, Rebekka
    Kelter, Gerhard
    Maier, Armin
    Fiebig, Heinz-Herbert
    Beckers, Thomas
    [J]. CANCER RESEARCH, 2011, 71
  • [45] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Kim, Hyoung
    Xu, Haineng
    George, Erin
    Hallberg, Dorothy
    Kumar, Sushil
    Jagannathan, Veena
    Medvedev, Sergey
    Kinose, Yasuto
    Devins, Kyle
    Verma, Priyanka
    Ly, Kevin
    Wang, Yifan
    Greenberg, Roger A.
    Schwartz, Lauren
    Johnson, Neil
    Scharpf, Robert B.
    Mills, Gordon B.
    Zhang, Rugang
    Velculescu, Victor E.
    Brown, Eric J.
    Simpkins, Fiona
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [46] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
    Hyoung Kim
    Haineng Xu
    Erin George
    Dorothy Hallberg
    Sushil Kumar
    Veena Jagannathan
    Sergey Medvedev
    Yasuto Kinose
    Kyle Devins
    Priyanka Verma
    Kevin Ly
    Yifan Wang
    Roger A. Greenberg
    Lauren Schwartz
    Neil Johnson
    Robert B. Scharpf
    Gordon B. Mills
    Rugang Zhang
    Victor E. Velculescu
    Eric J. Brown
    Fiona Simpkins
    [J]. Nature Communications, 11
  • [47] PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
    Xia Ding
    Zhou Zhu
    John Lapek
    Elizabeth A. McMillan
    Alexander Zhang
    Chi-Yeh Chung
    Sara Dubbury
    Jennifer Lapira
    Sarah Firdaus
    Xiaolin Kang
    Jingjin Gao
    Jon Oyer
    John Chionis
    Robert A. Rollins
    Lianjie Li
    Sherry Niessen
    Shubha Bagrodia
    Lianglin Zhang
    Todd VanArsdale
    [J]. Scientific Reports, 12
  • [48] Assessing the impact of immune therapy in the setting of PARP inhibitor resistance
    Miller, Marina Delazari
    Kinjyo, Ichiko
    Adams, Sarah Foster
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E11 - E12
  • [49] PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
    Ding, Xia
    Zhu, Zhou
    Lapek, John
    McMillan, Elizabeth A.
    Zhang, Alexander
    Chung, Chi-Yeh
    Dubbury, Sara
    Lapira, Jennifer
    Firdaus, Sarah
    Kang, Xiaolin
    Gao, Jingjin
    Oyer, Jon
    Chionis, John
    Rollins, Robert A.
    Li, Lianjie
    Niessen, Sherry
    Bagrodia, Shubha
    Zhang, Lianglin
    VanArsdale, Todd
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [50] Reversing PARP inhibitor resistance by targeting the replication stress response
    O'Connor, Mark J.
    Cruz, Cristina
    Castroviejo-Bermejo, Marta
    Polanska, Urszula M.
    Jones, Gemma N.
    Wang, Anderson
    Lai, Zhongwu
    Forment, Josep
    Bulusu, Krishna
    Llop-Guevara, Alba
    Dougherty, Brian
    Saura, Cristina
    Brough, Rachel
    Lord, Chris J.
    Bruna, Alejandra
    Caldas, Carlos
    Fawell, Stephen
    Barrett, J. Carl
    Critchlow, Susan E.
    Balmana, Judith
    Cadogan, Elaine
    Serra, Violeta
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345